Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum CULT Food Science Corp C.CULT

Alternate Symbol(s):  CULTF

CULT Food Science Corp. operates an investment platform, which is focused on the development and commercialization of cellular agricultural technologies and products. It is advancing the development of technologies to provide sustainable, environmental, and ethical solutions to the global factory farming and aquaculture crises. Its products include Noochies!, Zero Coffee and Free Candy... see more

CSE:CULT - Post Discussion

CULT Food Science Corp > BSF Enterprise PLC
View:
Post by maoae7 on May 18, 2022 8:14am

BSF Enterprise PLC

"3D Bio-Tissues has already produced a replacement human cornea and another of its targets is to produce the UK's first 100% lab-grown meat in the next 12 months"

https://ca.paidpromotionalmessages.com/companies/news/982450/bsf-enterprise-wraps-up-purchase-of-lab-grown-skin-cornea-and-meat-developer-982450.html
Comment by maoae7 on May 18, 2022 8:23am
sorry the link. You can reach the whole article with a google search i guess. I don't expect to get rich overnight with CULT. I buy the dips carefully.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities